Your browser doesn't support javascript.
loading
Protective strategies to prevent trastuzumab-induced cardiotoxicity - Authors' reply.
Earl, Helena M; Hiller, Louise; Plummer, Chris; Miles, David; Wardley, Andrew M; Cameron, David A; Dunn, Janet A.
Afiliación
  • Earl HM; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research (NIHR), Cambridge Biomedical Res
  • Hiller L; Warwick Clinical Trials Unit, University of Warwick, Coventry, UK.
  • Plummer C; Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Freeman Hospital, Newcastle upon Tyne, UK.
  • Miles D; Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK.
  • Wardley AM; Research and Development, NIHR Manchester Clinical Research Facility, Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Cameron DA; Cancer Edinburgh Research Centre, The Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK.
  • Dunn JA; Warwick Clinical Trials Unit, University of Warwick, Coventry, UK.
Lancet ; 395(10223): 492-493, 2020 02 15.
Article en En | MEDLINE | ID: mdl-32061290
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Cardiotoxicidad Límite: Humans Idioma: En Revista: Lancet Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Cardiotoxicidad Límite: Humans Idioma: En Revista: Lancet Año: 2020 Tipo del documento: Article